Skip to main content
Top
Published in: Journal of Translational Medicine 1/2019

Open Access 01-12-2019 | Obesity | Review

The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide

Authors: Giovanna Muscogiuri, Luigi Barrea, Daniela Laudisio, Gabriella Pugliese, Ciro Salzano, Silvia Savastano, Annamaria Colao

Published in: Journal of Translational Medicine | Issue 1/2019

Login to get access

Abstract

The epidemic of obesity is growing steadily across the whole world. Obesity is not only a merely aesthetic disease but is the “mother” of most chronic diseases such as associated with a range of type 2 diabetes, cardiovascular disease, obstructive sleep apnea, and cancer. However, although there is a need to find a strategy to stop this epidemic disease, most of the times the current nutritional strategies are not effective in weight loss and in long term weight maintenance. Very low-calorie ketogenic diets (VLCKD) is increasingly establishing as a successful nutritional pattern to manage obesity; this is due to rapid weight loss that gives rise to a positive psychological cycle which in turn increases the compliance to diet. Another important key point of VLCKD is the ability to preserve fatty free mass which is known to play a role of paramount importance in glucose metabolism. Despite the clinical evidence of VLCKD there are paucity of data regarding to its management. Therefore, we will provide a useful guide to be used by nutrition experts taking care of subjects with obesity. In particular, we will report recommendations on the correct use of this therapeutic approach for weight loss and management of side effects.
Literature
2.
go back to reference Jastreboff AM, Kotz CM, Kahan S, Kelly AS, Heymsfield SB. Obesity as a disease: the obesity society 2018 position statement. Obesity (Silver Spring). 2019;27:7–9.CrossRef Jastreboff AM, Kotz CM, Kahan S, Kelly AS, Heymsfield SB. Obesity as a disease: the obesity society 2018 position statement. Obesity (Silver Spring). 2019;27:7–9.CrossRef
4.
go back to reference Brehm BJ, Seeley RJ, Daniels SR, D’Alessio DA. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab. 2003;88:1617–23.PubMedCrossRef Brehm BJ, Seeley RJ, Daniels SR, D’Alessio DA. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab. 2003;88:1617–23.PubMedCrossRef
5.
go back to reference Siraj ES, Williams KJ. another agent for obesity-will this time be different? N Engl J Med. 2015;373:82–3.PubMedCrossRef Siraj ES, Williams KJ. another agent for obesity-will this time be different? N Engl J Med. 2015;373:82–3.PubMedCrossRef
6.
8.
go back to reference Luat AF, Coyle L, Kamat D. The ketogenic diet: a practical guide for pediatricians. Pediatr Ann. 2016;45:e446–50.PubMedCrossRef Luat AF, Coyle L, Kamat D. The ketogenic diet: a practical guide for pediatricians. Pediatr Ann. 2016;45:e446–50.PubMedCrossRef
9.
go back to reference Merra G, Gratteri S, De Lorenzo A, Barrucco S, Perrone MA, Avolio E, Bernardini S, Marchetti M, Di Renzo L. Effects of very-low-calorie diet on body composition, metabolic state, and genes expression: a randomized double-blind placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2017;21:329–45.PubMed Merra G, Gratteri S, De Lorenzo A, Barrucco S, Perrone MA, Avolio E, Bernardini S, Marchetti M, Di Renzo L. Effects of very-low-calorie diet on body composition, metabolic state, and genes expression: a randomized double-blind placebo-controlled trial. Eur Rev Med Pharmacol Sci. 2017;21:329–45.PubMed
10.
go back to reference Garbow JR, Doherty JM, Schugar RC, Travers S, Weber ML, Wentz AE, Ezenwajiaku N, Cotter DG, Brunt EM, Crawford PA. Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet. Am J Physiol Gastrointest Liver Physiol. 2011;300:G956–67.PubMedPubMedCentralCrossRef Garbow JR, Doherty JM, Schugar RC, Travers S, Weber ML, Wentz AE, Ezenwajiaku N, Cotter DG, Brunt EM, Crawford PA. Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet. Am J Physiol Gastrointest Liver Physiol. 2011;300:G956–67.PubMedPubMedCentralCrossRef
11.
go back to reference Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, Humala N, Thiyagarajan M, Wang J, Pasinetti GM. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006;7:29.PubMedPubMedCentralCrossRef Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, Humala N, Thiyagarajan M, Wang J, Pasinetti GM. A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006;7:29.PubMedPubMedCentralCrossRef
12.
go back to reference Krebs HA. The regulation of the release of ketone bodies by the liver. Adv Enzyme Regul. 1966;4:339–54.PubMedCrossRef Krebs HA. The regulation of the release of ketone bodies by the liver. Adv Enzyme Regul. 1966;4:339–54.PubMedCrossRef
13.
go back to reference Kossoff EH, Zupec-Kania BA, Rho JM. Ketogenic diets: an update for child neurologists. J Child Neurol. 2009;24:979–88.PubMedCrossRef Kossoff EH, Zupec-Kania BA, Rho JM. Ketogenic diets: an update for child neurologists. J Child Neurol. 2009;24:979–88.PubMedCrossRef
14.
go back to reference Bueno NB, de Melo IS, de Oliveira SL, da Rocha Ataide T. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr. 2013;110:1178–87.PubMedCrossRef Bueno NB, de Melo IS, de Oliveira SL, da Rocha Ataide T. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr. 2013;110:1178–87.PubMedCrossRef
15.
go back to reference Al-Khalifa A, Mathew TC, Al-Zaid NS, Mathew E, Dashti HM. Therapeutic role of low-carbohydrate ketogenic diet in diabetes. Nutrition. 2009;25:1177–85.PubMedCrossRef Al-Khalifa A, Mathew TC, Al-Zaid NS, Mathew E, Dashti HM. Therapeutic role of low-carbohydrate ketogenic diet in diabetes. Nutrition. 2009;25:1177–85.PubMedCrossRef
16.
go back to reference Sharman MJ, Kraemer WJ, Love DM, Avery NG, Gomez AL, Scheett TP, Volek JS. A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J Nutr. 2002;132:1879–85.PubMedCrossRef Sharman MJ, Kraemer WJ, Love DM, Avery NG, Gomez AL, Scheett TP, Volek JS. A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men. J Nutr. 2002;132:1879–85.PubMedCrossRef
17.
go back to reference Boulter PR, Hoffman RS, Arky RA. Pattern of sodium excretion accompanying starvation. Metabolism. 1973;22:675–83.PubMedCrossRef Boulter PR, Hoffman RS, Arky RA. Pattern of sodium excretion accompanying starvation. Metabolism. 1973;22:675–83.PubMedCrossRef
18.
go back to reference Saudek CD, Boulter PR, Arky RA. The natriuretic effect of glucagon and its role in starvation. J Clin Endocrinol Metab. 1973;36:761–5.PubMedCrossRef Saudek CD, Boulter PR, Arky RA. The natriuretic effect of glucagon and its role in starvation. J Clin Endocrinol Metab. 1973;36:761–5.PubMedCrossRef
20.
go back to reference Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, Mariani S, Lubrano C, Poggiogalle E, Migliaccio S, et al. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). J Endocrinol Invest. 2019;42(11):1365–86.PubMedCrossRef Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, Mariani S, Lubrano C, Poggiogalle E, Migliaccio S, et al. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). J Endocrinol Invest. 2019;42(11):1365–86.PubMedCrossRef
21.
go back to reference Yumuk V, Fruhbeck G, Oppert JM, Woodward E, Toplak H. An EASO position statement on multidisciplinary obesity management in adults. Obes Facts. 2014;7:96–101.PubMedPubMedCentralCrossRef Yumuk V, Fruhbeck G, Oppert JM, Woodward E, Toplak H. An EASO position statement on multidisciplinary obesity management in adults. Obes Facts. 2014;7:96–101.PubMedPubMedCentralCrossRef
22.
go back to reference Stegenga H, Haines A, Jones K, Wilding J, Guideline Development G. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ. 2014;349:g6608.PubMedCrossRef Stegenga H, Haines A, Jones K, Wilding J, Guideline Development G. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ. 2014;349:g6608.PubMedCrossRef
27.
go back to reference Barbanti P, Fofi L, Aurilia C, Egeo G, Caprio M. Ketogenic diet in migraine: rationale, findings and perspectives. Neurol Sci. 2017;38:111–5.PubMedCrossRef Barbanti P, Fofi L, Aurilia C, Egeo G, Caprio M. Ketogenic diet in migraine: rationale, findings and perspectives. Neurol Sci. 2017;38:111–5.PubMedCrossRef
28.
go back to reference Kang HC, Chung DE, Kim DW, Kim HD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia. 2004;45:1116–23.PubMedCrossRef Kang HC, Chung DE, Kim DW, Kim HD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia. 2004;45:1116–23.PubMedCrossRef
29.
go back to reference Balasse EO, Ooms HA, Lambilliotte JP. Evidence for a stimulatory effect of ketone bodies on insulin secretion in man. Horm Metab Res. 1970;2:371–2.PubMedCrossRef Balasse EO, Ooms HA, Lambilliotte JP. Evidence for a stimulatory effect of ketone bodies on insulin secretion in man. Horm Metab Res. 1970;2:371–2.PubMedCrossRef
30.
go back to reference Franssila-Kallunki A, Rissanen A, Ekstrand A, Ollus A, Groop L. Weight loss by very-low-calorie diets: effects on substrate oxidation, energy expenditure, and insulin sensitivity in obese subjects. Am J Clin Nutr. 1992;56:247S–8S.PubMedCrossRef Franssila-Kallunki A, Rissanen A, Ekstrand A, Ollus A, Groop L. Weight loss by very-low-calorie diets: effects on substrate oxidation, energy expenditure, and insulin sensitivity in obese subjects. Am J Clin Nutr. 1992;56:247S–8S.PubMedCrossRef
31.
go back to reference Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54:2506–14.PubMedPubMedCentralCrossRef Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54:2506–14.PubMedPubMedCentralCrossRef
32.
go back to reference Wheless JW, Ashwal S. The ketogenic diet. In: Swaiman KF, editor. Pediatric neurology: principles and practice. Philadelphia: Mosby; 1999. Wheless JW, Ashwal S. The ketogenic diet. In: Swaiman KF, editor. Pediatric neurology: principles and practice. Philadelphia: Mosby; 1999.
34.
go back to reference Stewart WA, Gordon K, Camfield P. Acute pancreatitis causing death in a child on the ketogenic diet. J Child Neurol. 2001;16:682.PubMedCrossRef Stewart WA, Gordon K, Camfield P. Acute pancreatitis causing death in a child on the ketogenic diet. J Child Neurol. 2001;16:682.PubMedCrossRef
35.
go back to reference Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am. 1990;19:783–91.PubMed Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am. 1990;19:783–91.PubMed
36.
go back to reference Chapman SA, Wacksman GP, Patterson BD. Pancreatitis associated with valproic acid: a review of the literature. Pharmacotherapy. 2001;21:1549–60.PubMedCrossRef Chapman SA, Wacksman GP, Patterson BD. Pancreatitis associated with valproic acid: a review of the literature. Pharmacotherapy. 2001;21:1549–60.PubMedCrossRef
37.
go back to reference Palgi A, Read JL, Greenberg I, Hoefer MA, Bistrian BR, Blackburn GL. Multidisciplinary treatment of obesity with a protein-sparing modified fast: results in 668 outpatients. Am J Public Health. 1985;75:1190–4.PubMedPubMedCentralCrossRef Palgi A, Read JL, Greenberg I, Hoefer MA, Bistrian BR, Blackburn GL. Multidisciplinary treatment of obesity with a protein-sparing modified fast: results in 668 outpatients. Am J Public Health. 1985;75:1190–4.PubMedPubMedCentralCrossRef
38.
go back to reference Ballaban-Gil K, Callahan C, O’Dell C, Pappo M, Moshe S, Shinnar S. Complications of the ketogenic diet. Epilepsia. 1998;39:744–8.PubMedCrossRef Ballaban-Gil K, Callahan C, O’Dell C, Pappo M, Moshe S, Shinnar S. Complications of the ketogenic diet. Epilepsia. 1998;39:744–8.PubMedCrossRef
39.
go back to reference Nishizawa Y, Koyama H, Shoji T, Tahara H, Hagiwara S, Aratani H, Nakatsuka K, Miki T, Morii H. Altered calcium homeostasis accompanying changes of regional bone mineral during a very-low-calorie diet. Am J Clin Nutr. 1992;56:265S–7S.PubMedCrossRef Nishizawa Y, Koyama H, Shoji T, Tahara H, Hagiwara S, Aratani H, Nakatsuka K, Miki T, Morii H. Altered calcium homeostasis accompanying changes of regional bone mineral during a very-low-calorie diet. Am J Clin Nutr. 1992;56:265S–7S.PubMedCrossRef
40.
go back to reference Davie MW, Abraham RR, Hewins B, Wynn V. Changes in bone and muscle constituents during dieting for obesity. Clin Sci (Lond). 1986;70:285–93.CrossRef Davie MW, Abraham RR, Hewins B, Wynn V. Changes in bone and muscle constituents during dieting for obesity. Clin Sci (Lond). 1986;70:285–93.CrossRef
41.
go back to reference Andersen RE, Wadden TA, Herzog RJ. Changes in bone mineral content in obese dieting women. Metabolism. 1997;46:857–61.PubMedCrossRef Andersen RE, Wadden TA, Herzog RJ. Changes in bone mineral content in obese dieting women. Metabolism. 1997;46:857–61.PubMedCrossRef
42.
go back to reference Howard AN, Kreitzman SN. The Swansea trial: body composition and metabolic studies with a very-low-calorie diet (VLCD). London: Smith-Gordon; 1993. ISBN 1854630709. Howard AN, Kreitzman SN. The Swansea trial: body composition and metabolic studies with a very-low-calorie diet (VLCD). London: Smith-Gordon; 1993. ISBN 1854630709.
43.
44.
go back to reference Swink TD, Vining EP, Freeman JM. The ketogenic diet: 1997. Adv Pediatr. 1997;44:297–329.PubMed Swink TD, Vining EP, Freeman JM. The ketogenic diet: 1997. Adv Pediatr. 1997;44:297–329.PubMed
45.
go back to reference Furth SL, Casey JC, Pyzik PL, Neu AM, Docimo SG, Vining EP, Freeman JM, Fivush BA. Risk factors for urolithiasis in children on the ketogenic diet. Pediatr Nephrol. 2000;15:125–8.PubMedCrossRef Furth SL, Casey JC, Pyzik PL, Neu AM, Docimo SG, Vining EP, Freeman JM, Fivush BA. Risk factors for urolithiasis in children on the ketogenic diet. Pediatr Nephrol. 2000;15:125–8.PubMedCrossRef
46.
go back to reference Kielb S, Koo HP, Bloom DA, Faerber GJ. Nephrolithiasis associated with the ketogenic diet. J Urol. 2000;164:464–6.PubMedCrossRef Kielb S, Koo HP, Bloom DA, Faerber GJ. Nephrolithiasis associated with the ketogenic diet. J Urol. 2000;164:464–6.PubMedCrossRef
47.
go back to reference Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med. 1993;119:1029–35.PubMedCrossRef Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med. 1993;119:1029–35.PubMedCrossRef
48.
go back to reference Festi D, Colecchia A, Larocca A, Villanova N, Mazzella G, Petroni ML, Romano F, Roda E. Review: low caloric intake and gall-bladder motor function. Aliment Pharmacol Ther. 2000;14(Suppl 2):51–3.PubMedCrossRef Festi D, Colecchia A, Larocca A, Villanova N, Mazzella G, Petroni ML, Romano F, Roda E. Review: low caloric intake and gall-bladder motor function. Aliment Pharmacol Ther. 2000;14(Suppl 2):51–3.PubMedCrossRef
49.
50.
go back to reference Johansson K, Sundstrom J, Marcus C, Hemmingsson E, Neovius M. Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-year matched cohort study. Int J Obes (Lond). 2014;38:279–84.CrossRef Johansson K, Sundstrom J, Marcus C, Hemmingsson E, Neovius M. Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-year matched cohort study. Int J Obes (Lond). 2014;38:279–84.CrossRef
51.
Metadata
Title
The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide
Authors
Giovanna Muscogiuri
Luigi Barrea
Daniela Laudisio
Gabriella Pugliese
Ciro Salzano
Silvia Savastano
Annamaria Colao
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2019
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-019-2104-z

Other articles of this Issue 1/2019

Journal of Translational Medicine 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.